Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_provenance.
- NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_assertion description "[LZTS1 has been shown to have tumour suppressor activities against prostate and breast cancer and is located within a region of frequent loss of heterozygosity (LOH) at 8p22 in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_provenance.
- NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_assertion evidence source_evidence_literature NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_provenance.
- NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_assertion SIO_000772 15876481 NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_provenance.
- NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_assertion wasDerivedFrom befree-2016 NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_provenance.
- NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_assertion wasGeneratedBy ECO_0000203 NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_provenance.
- befree-2016 importedOn "2016-02-19" NP493412.RA9WZgx2-tW8IA_GWL8xJEcTdMXIcHw2N6W8aQ3YUk9Mw130_provenance.